<DOC>
	<DOCNO>NCT01875796</DOCNO>
	<brief_summary>This project test feasibility utility novel , integrate approach treatment patient cannabis use disorder ( CUD ) anxiety disorder .</brief_summary>
	<brief_title>Integrated CBT Cannabis Dependence With Co-occurring Anxiety Disorders</brief_title>
	<detailed_description>Cannabis use disorder ( CUD ) common illicit substance dependence people CUD highly vulnerable anxiety disorder . The co-occurrence anxiety disorder among CUD press public health matter give elevate anxiety relate poor cannabis treatment outcome . Cannabis-related problem among anxiety disorder may maintain reliance cannabis manage anxiety . Investigations treatment condition co-occur virtually absent . Motivation enhancement therapy ( MET ) combine cognitive-behavioral therapy ( CBT ) efficacious intervention cannabis CUD , yet outcomes highly limited anxious patient . Transdiagnostic anxiety treatment facilitate treatment patient anxiety psychopathology regardless specific type anxiety disorder . One treatment , False Safety Behavior Elimination Treatment ( FSET ) , may particularly useful anxious patient CUD focus elimination behavior may effective decrease anxiety short-term , maintain even exacerbate anxiety long-term ( i.e. , false safety behavior ) . The use cannabis manage anxiety , therefore , target treatment . This project test feasibility utility novel , integrate approach treatment patient CUD anxiety disorder . Phase I project include development refinement specialize group protocol ( i.e. , Integrated Cannabis Anxiety Reduction Treatment ICART ) integrate MET-CBT CUD FSET . The initial protocol modify base experience gain group treatment integrate treatment . Phase II randomize control trial examine relative efficacy refine ICART treatment versus MET-CBT alone . After post-treatment assessment , ICART group follow 3 month examine maintenance gain ; participant originally assign control condition offer ICART . It hypothesize ICART produce good outcome control .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>1 . Diagnosis cannabis use disorder 2 . An additional diagnosis anxiety disorder 3 . Patient report least his/her cannabis use aim reduce anxiety and/or social facilitation . 4 . Patient report cannabis his/her substance choice anxiety management . 5 . Concurrent use psychotropic medication ( e.g. , selective serotonin reuptake inhibitor ) permit long patient stable dose least three month prior enter study willing remain stable medication duration treatment . 6 . Age 18 65 year . 7 . English language fluency . 8 . Willing able provide write informed consent . 1 . Alcohol illicit substance ( noncannabis ) dependence . 2 . Cannabis use behavior sufficiently uncontrolled proper participation study protocol would likely disrupt . 3 . History schizophrenia , bipolar disorder , organic brain syndrome . 4 . Prominent suicidal ideation intent judge clinically significant . 5 . Mental retardation another pervasive developmental disability ( e.g. , Asperger 's Disorder ) . 6 . Sufficiently socially unstable preclude completion study requirement ( e.g. , homeless ) . 7 . Prior simultaneous cognitive behavioral treatment cannabis dependence anxiety disorder . 8 . Legally mandate receive substance abuse treatment . 9 . Report current participation intent participate additional ( i.e. , treatment METCBT MET alone ) anxiety substance abuse treatment method course study . 10 . Unwilling maintain stable dose regularlydosed medication study 11 . Unwilling cease PRN ( pro nata `` need '' ) use benzodiazepine fastacting anxiolytic prior entrance social situation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cannabis</keyword>
	<keyword>marijuana</keyword>
	<keyword>anxiety</keyword>
	<keyword>transdiagnostic</keyword>
	<keyword>dual diagnosis</keyword>
	<keyword>cannabis abuse</keyword>
	<keyword>cannabis dependence</keyword>
	<keyword>cannabis use disorder</keyword>
</DOC>